The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Open accessAbstract
OBJECTIVE: To examine the independent and interactive influences of neuroimaging biomarkers on retrospective cognitive decline. METHODS: F-AV-45) amyloid PET scan, and a structural MRI scan were recruited from the Knight Alzheimer Disease Research Center at Washington University in St. Louis. Cognition was assessed with standard measures reflecting episodic memory, executive functioning, semantic fluency, and processing speed. RESULTS: Results from retrospective longitudinal analyses showed that each biomarker had a univariate association with the global cognitive composite; however, when each marker was analyzed in a single statistical model, only tau was a significant predictor of global cognitive decline. There was an interaction between tau and amyloid such that tau-related cognitive decline was worse in individuals with high amyloid. There was also an interaction with hippocampal volume indicating that individuals with high levels of all 3 pathologies exhibited the greatest declines in cognition. Additional analyses within each cognitive domain indicated that tau had the largest negative influence on tests of episodic memory and executive functioning. CONCLUSIONS: Together, these results suggest that increasing levels of tau most consistently relate to declines in cognition preceding biomarker collection. These findings support models of Alzheimer disease (AD) staging that suggest that elevated β-amyloid alone may be insufficient to produce cognitive change in individuals at risk for AD and support the use of multiple biomarkers to stage AD progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, cross-sectional and longitudinal human cohort studies of biomarkers support a scenario in which amyloid pathology (Aβ42 lowering in CSF, positive amyloid PET imaging) precedes tau pathology (tau-PET and phospho-Tau elevation in CSF) and then neurodegeneration 126-128 .”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citationA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., Hampel, H., Jagust, W. J., Johnson, K. A., Knopman, D. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002923 · Cited by 1,864
Buckner, R. L., Head, D. M., Parker, J. B., Fotenos, A. F., Marcus, D. S., Morris, J. C., & Snyder, A. Z. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.018 · Cited by 1,325
Self-citationPET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Screening for dementia by memory testing
Grober, E. H., Herman Buschke, L., Crystal, H., Bang, S., & Dresner, R. (1988) · Neurology · doi:10.1212/wnl.38.6.900 · Cited by 956
Correction for partial volume effects in PET: principle and validation.
ROUSSET, O. G., Ma, Y., & Evans, A. C. (1998) · PubMed · Cited by 919
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734
Self-citation
Research works printed but not linked: 1
- Goodglass H, Kaplan E. Boston Diagnostic Aphasia Examination Booklet, III: Oral Expression: Animal Naming (Fluency in Controlled Association). Philadelphia: Lea & Febiger; 1983.
Cited by
Sorted by citations
Items 101–200 of 291
Hu, X., Meier, M., & Pruessner, J. C. (2023) · Brain and Behavior · doi:10.1002/brb3.2925 · Cited by 24
Relationship between brain AD biomarkers and episodic memory performance in healthy aging
Rizzolo, L., Narbutas, J., Egroo, M. V., Chylinski, D., Besson, G., Baillet, M., Bahri, M. A., Salmon, É., Maquet, P., Vandewalle, G., et al. (2021) · Brain and Cognition · doi:10.1016/j.bandc.2020.105680 · Cited by 29
Rankovic, M., & Zweckstetter, M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.014 · Cited by 25
McKay, N. S., Millar, P. R., Nicosia, J., Aschenbrenner, A. J., Gordon, B. A., Benzinger, T. L. S., Cruchaga, C. C., Schindler, S. E., Morris, J. C., & Hassenstab, J. J. (2024) · Neuropsychology · doi:10.1037/neu0000949 · Cited by 24
Self-citationAschenbrenner, A. J., Gordon, B. A., Fagan, A. M., Schindler, S. E., Balota, D. A., Morris, J. C., & Hassenstab, J. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200018 · Cited by 23
Self-citationGenetically identical twins show comparable tau PET load and spatial distribution
Coomans, E. M., Tomassen, J., Ossenkoppele, R., Golla, S. S. V., den Hollander, M. E., Collij, L. E., Weltings, E., van der Landen, S. M., Wolters, E. E., Windhorst, A. D., et al. (2022) · Brain · doi:10.1093/brain/awac004 · Cited by 23
Roccati, E., Collins, J. M., Bindoff, A. D., Alty, J., Bartlett, L., King, A. E., & Vickers, J. C. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.06.018 · Cited by 21
Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
Rafii, M. S. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22658 · Cited by 23
Tsoy, E., Strom, A., Iaccarino, L., Erlhoff, S. J., Goode, C. A., Rodriguez, A.-M., Rabinovici, G. D., Miller, B. L., Kramer, J. H., Rankin, K. P., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00776-w · Cited by 23
Biomarkers and Tools for Predicting Alzheimer’s Disease in the Preclinical Stage
Li, T.-R., Yang, Q. Z., Hu, X., & Han, Y. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524153901 · Cited by 23
Visser, D., Verfaillie, S. C. J., Wolters, E. E., Coomans, E. M., Timmers, T., Tuncel, H., Boellaard, R., Golla, S. S. V., Windhorst, A. D., Scheltens, P., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05669-6 · Cited by 19
Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint
Thomas, K. R., Weigand, A. J., Edwards, L. C., Edmonds, E. C., Bangen, K. J., Ortiz, G., Walker, K. S., Bondi, M. W., & Initiative, A. D. N. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01060-1 · Cited by 23
Mendes, A. J., Ribaldi, F., Lathuilière, A., Ashton, N. J., Zetterberg, H., Abramowicz, M., Scheffler, M., Assal, F., Garibotto, V., Blennow, K., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01478-9 · Cited by 23
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 20
Pelgrim, T. A. D., Beran, M., Twait, E. L., Geerlings, M. I., & Vonk, J. M. J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101449 · Cited by 21
Naproxen for presymptomatic Alzheimer disease
Hershey, L. A., & Lipton, R. B. (2019) · Neurology · doi:10.1212/wnl.0000000000007233 · Cited by 20
Brain Molecular Connectivity in Neurodegenerative Conditions
Carli, G., Tondo, G., Boccalini, C., & Perani, D. (2021) · Brain Sciences · doi:10.3390/brainsci11040433 · Cited by 20
Hippocampal subfield associations with memory depend on stimulus modality and retrieval mode
Aumont, É., Bussy, A., Bédard, M., Bezgin, G., Therriault, J., Savard, M., Arias, J. F., Sziklas, V., Vitali, P., Poltronetti, N. M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad309 · Cited by 23
Kumar, S., Earnest, T., Yang, B., Kothapalli, D., Aschenbrenner, A. J., Hassenstab, J. J., Xiong, C., Ances, B. M., Morris, J. C., Benzinger, T. L. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70143 · Cited by 20
Self-citationPuliatti, G., Puma, D. D. L., Aceto, G., Lazzarino, G., Acquarone, E., Mangione, R., D'adamio, L., Ripoli, C., Arancio, O., Piacentini, R., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102482 · Cited by 19
Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease
Buckley, R. F. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01026-5 · Cited by 18
Narbutas, J., Chylinski, D., Egroo, M. V., Bahri, M. A., Koshmanova, E., Besson, G., Muto, V., Schmidt, C., Luxen, A., Balteau, E., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.666181 · Cited by 23
Biomarkers and Tools for Predicting Alzheimer's Disease in the Preclinical Stage
Li, T., Yang, Q. Z., Hu, X., & Han, Y. (2022) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 17
Qi, W., Zhu, X., He, D., Wang, B., Cao, S., Dong, C., Li, Y., Chen, Y., Wang, B., Shi, Y., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/57830 · Cited by 18
In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice
Davidowitz, E. J., Krishnamurthy, P., Lopez, P. L. D. C., Jimenez, H. T., Adrien, L. R., Davies, P., & Moe, J. G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190465 · Cited by 18
Millar, P. R., Ances, B. M., Gordon, B. A., Benzinger, T. L. S., Morris, J. C., & Balota, D. A. (2020) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_01645 · Cited by 15
Self-citationMoscoso, A., Grothe, M. J., Schöll, M., & Initiative, A. D. N. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05195-5 · Cited by 16
Uncovering tau in wasteosomes (corpora amylacea) of Alzheimer’s disease patients
Riba, M., del Valle, J., Romera, C., Alsina, R., Molina‐Porcel, L., Pelegrı́, C., & Vilaplana, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1110425 · Cited by 16
Li, T., Dong, Q., Jiang, X., Kang, G., Li, X., Xie, Y., Jiang, J., & Han, Y. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102900 · Cited by 16
Sadleir, K. R., Gómez, K., Edwards, A. E., Patel, A. J., Ley, M. L., Khatri, A. W., Guo, J., Mahesh, S., Watkins, E. A., Popović, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02888-1 · Cited by 18
Kothapalli, S. V. V. N., Benzinger, T. L. S., Aschenbrenner, A. J., Perrin, R. J., Hildebolt, C. F., Goyal, M. S., Fagan, A. M., Raichle, M. E., Morris, J. C., & Yablonskiy, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210503 · Cited by 15
Self-citationLao, P. J., Boehme, A. K., Morales, C. D., Laing, K. K., Chesebro, A. G., Igwe, K. C., Gutierrez, J., Gu, Y., Stern, Y., Schupf, N., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.05.004 · Cited by 16
Qiao, Z., Wang, G., Zhao, X. B., Wang, K., Fan, D., Chen, Q., & Ai, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.841942 · Cited by 15
Medial temporal tau predicts memory decline in cognitively unimpaired elderly
Kwan, A. T. H., Arfaie, S., Therriault, J., Azizi, Z., Lussier, F. Z., Tissot, C., Chamoun, M., Bezgin, G., Servaes, S., Stevenon, J., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac325 · Cited by 15
Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
Uretsky, M., Gibbons, L. E., Mukherjee, S., Trittschuh, E. H., Fardo, D. W., Boyle, P. A., Keene, C. D., Saykin, A. J., Crane, P. K., Schneider, J. A., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12201 · Cited by 19
Doherty, J. M., Roe, C. M., Murphy, S. A., Johnson, A. M., Fleischer, E., Toedebusch, C. D., Redrick, T., Freund, D., Morris, J. C., Schindler, S. E., et al. (2022) · SLEEP · doi:10.1093/sleep/zsac070 · Cited by 16
Self-citationNielsen, K. D., & Boenink, M. (2019) · Journal of Responsible Innovation · doi:10.1080/23299460.2019.1676687 · Cited by 15
Montandon, M., Herrmann, F. R., Garibotto, V., Rodriguez, C. K., Haller, S., & Giannakopoulos, P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.002 · Cited by 15
Bernier, R. A., Banks, S. J., Panizzon, M. S., Andrews, M., Jacobs, E. G., Galasko, D. R., Shepherd, A. L., Akassoglou, K., Sundermann, E. E., & Initiative, A. D. N. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12284 · Cited by 13
Doherty, J. M., Murphy, S. A., Bayat, S., Wisch, J. K., Johnson, A. M., Walker, A. I. B., Schindler, S. E., Ances, B. M., Morris, J. C., & Babulal, G. M. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12852 · Cited by 14
Self-citationLei, H., Pi, G., He, T., Xiong, R., Lv, J., Liu, J.-L., Wu, D., Li, M., Shi, K., Li, S., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00512-z · Cited by 14
Allison, S. L., Jonaitis, E. M., Koscik, R. L., Hermann, B. P., Mueller, K. D., Cary, R. P., Ma, Y., Rowley, H. A., Carlsson, C. M., Asthana, S., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.030 · Cited by 15
AD molecular: Imaging tau aggregates with positron emissions tomography
Betthauser, T. J. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.007 · Cited by 14
Vasilevskaya, A., Taghdiri, F., Multani, N., Anor, C. J., Misquitta, K., Houle, S., Burke, C., Tang‐Wai, D. F., Lang, A. E., Fox, S. H., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00574 · Cited by 17
ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
Lennol, M. P., Bordier, C., Kamelher, L., Ulrich, J. D., Holtzman, D. M., & Gratuze, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250965 · Cited by 14
Hassenstab, J. J., Nicosia, J., LaRose, M., Aschenbrenner, A. J., Gordon, B. A., Benzinger, T. L. S., Xiong, C., & Morris, J. C. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00894-5 · Cited by 13
Self-citationCensi, S. T., Sestieri, C., Punzi, M., Pizzi, A. D., Ferretti, A., Gambi, F., Tomassini, V., Pizzi, S. D., & Sensi, S. L. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.42 · Cited by 14
Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults
Harrington, K., Aschenbrenner, A. J., Maruff, P. T., Masters, C. L., Fagan, A. M., Benzinger, T. L. S., Gordon, B. A., Cruchaga, C., Morris, J. C., & Hassenstab, J. J. (2021) · Psychological Science · doi:10.1177/0956797620985518 · Cited by 12
Self-citationBhattarai, P., Taha, A., Soni, B., Thakuri, D. S., Ritter, E., & Chand, G. B. (2023) · Brain Informatics · doi:10.1186/s40708-023-00213-8 · Cited by 10
Li, K., Shacham, E., Brown, D. C., Blake, M., Zhu, Y.-Q., Trani, J., & Babulal, G. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70373 · Cited by 14
Rullmann, M., McLeod, A., Grothe, M. J., Sabri, O., & Barthel, H. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.238477 · Cited by 12
Ganguly, D., Thomas, J. A., Ali, A., & Kumar, R. K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15591 · Cited by 12
Mohamed, A. Z., Cumming, P. D., Nasrallah, F. A., & Initiative, A. D. N. (2022) · Brain Sciences · doi:10.3390/brainsci12070876 · Cited by 12
Tristão‐Pereira, C., Langella, S., Sanchez, J. S., Malotaux, V., He, B., Alcina, J., Martinez, J. E., Rubinstein, Z. B., Baena, A. Y., Vila‐Castelar, C., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01711-z · Cited by 14
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
Fornari, C., Mori, F., Zoppi, N., Libri, I., Silvestri, C., Cosseddu, M., Turrone, R., Maffi, M., Caratozzolo, S., Borroni, B., et al. (2022) · Neurology International · doi:10.3390/neurolint14020029 · Cited by 11
Zhao, X., Yang, A., Zhang, Z.-C., Yang, Y., & Zhao, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad060 · Cited by 10
Pathobiolgy and Management of Alzheimer's Disease
Kim, H., & Chung, J. Y. (2021) · Chonnam Medical Journal · doi:10.4068/cmj.2021.57.2.108 · Cited by 11
Hartz, S. M., Mozersky, J. T., Schindler, S. E., Linnenbringer, E. L., Wang, J., Gordon, B. A., Raji, C. A., Moulder, K. L., West, T., Benzinger, T. L. S., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12781 · Cited by 10
Self-citationZiontz, J., Harrison, T. M., Fonseca, C. S., Giorgio, J., Han, F., Lee, J., Jagust, W. J., & Initiative, A. D. N. (2024) · Human Brain Mapping · doi:10.1002/hbm.70083 · Cited by 10
Matsuda, H., Hanyu, H., Kaneko, C., Ogura, M., & Yamao, T. (2025) · Annals of Nuclear Medicine · doi:10.1007/s12149-025-02018-7 · Cited by 10
Malpetti, M., Rathore, S., Iaccarino, L., Joie, R. L., Tronchin, G., Wessels, A. M., Sims, J. R., Pontecorvo, M. J., Shcherbinin, S., & Rabinovici, G. D. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01868-7 · Cited by 10
Cerebral blood flow, tau imaging, and memory associations in cognitively unimpaired older adults
Weigand, A. J., Hamlin, A. M., Breton, J., & Clark, A. L. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100153 · Cited by 10
Emmerson, J. T., Carmo, S. D., Liu, Y., Shalhoub, A., Ai, L., Bonomo, Q., Malcolm, J. C., Breuillaud, L., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106227 · Cited by 11
Divya, R., & Kumari, R. S. S. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105254 · Cited by 9
Brain iron accumulation in neurodegenerative disorders: Does air pollution play a role?
George, J. V., Hornburg, K. J., Merrill, A. K., Marvin, E., Conrad, K., Welle, K. A., Gelein, R. M., Chalupa, D., Graham, U. M., Oberdörster, G., et al. (2025) · Particle and Fibre Toxicology · doi:10.1186/s12989-025-00622-z · Cited by 9
Targeting tau in Alzheimer’s Disease: rationale, approach and challenges
Aslanyan, A., Foiani, M. S., Giovannucci, T. A., McDade, E., Duff, K., Mummery, C. J., Schöll, M., Wildsmith, K. R., & Paterson, R. W. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00925-5 · Cited by 10
Plasma NfL is associated with mild cognitive decline in patients with diabetes
Marutani, N., Akamine, S., Kanayama, D., Gotoh, S., Yanagida, K., Maruyama, R., Mori, K., Miyamoto, T., Adachi, H., Sakagami, Y., et al. (2022) · Psychogeriatrics · doi:10.1111/psyg.12819 · Cited by 9
Yasuno, F., Kimura, Y., Ogata, A., Ikenuma, H., Abe, J., Minami, H., Nihashi, T., Yokoi, K., Hattori, S., Shimoda, N., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.027 · Cited by 9
Li, S., Roy, E. R., Wang, Y., Watkins, T. A., & Cao, W. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03720-1 · Cited by 14
Kleiman, M. J., Ariko, T., Galvin, J. E., & Initiative, T. A. D. N. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220891 · Cited by 8
Hirschstein, Z., Vanga, G. R., Wang, G., Novakovic, Z. M., & Grasso, P. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129697 · Cited by 9
Neuroimaging Predictors of Cognitive Resilience against Alzheimer's Disease Pathology
Williams, M. E., Fennema‐Notestine, C., Bell, T. R., Lin, S., Glatt, S. J., Kremen, W. S., Elman, J. A., & Initiative, A. D. N. (2025) · Annals of Neurology · doi:10.1002/ana.27186 · Cited by 9
Bekena, S., Singh, R. K., Zhu, Y., Cruchaga, C., Arnold, S. E., Ances, B. M., & Babulal, G. M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378675 · Cited by 8
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 12
Wang, J., Sims, K. D., Ackley, S. F., Chen, R., Kobayashi, L. C., Hayes‐Larson, E., Mayeda, E. R., Buto, P. T., Zimmerman, S. C., Graff, R. E., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13497 · Cited by 8
Terrera, G. M., Harrison, J., Ritchie, C. W., & Ritchie, K. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191108 · Cited by 8
Gaudreault, R., Hervé, V., van de Ven, T. G. M., Mousseau, N., & Ramassamy, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201549 · Cited by 8
Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories
Ackley, S. F., Hayes‐Larson, E., Brenowitz, W. D., Swinnerton, K. N., Mungas, D., Fletcher, E. M., Singh, B., Whitmer, R. A., DeCarli, C. S., & Glymour, M. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102713 · Cited by 8
Bi, X.-A., Mao, Y., Luo, S., Wu, H., Zhang, L., Luo, X., & Xu, L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac454 · Cited by 9
Tau in dementia with Lewy bodies
Chin, K. S., Churilov, L. P., Doré, V., Villemagne, V. L., Rowe, C. C., Yassi, N., & Watson, R. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231177219 · Cited by 7
The molecular pathology of neurodegenerative and psychiatric disorders
Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 8
Role of proline‐rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease
Kumar, R. K., Tiwari, V., & Dey, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15569 · Cited by 9
Wassef, H. R., & Colletti, P. M. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004252 · Cited by 7
Levine, T. F., Roe, C. M., Babulal, G. M., Fagan, A. M., & Head, D. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000487 · Cited by 7
Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition
Weigand, A. J., Initiative, A. D. N., Macomber, A. J., Walker, K. S., Edwards, L., Thomas, K. R., Bangen, K. J., Nation, D. A., & Bondi, M. W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220026 · Cited by 7
Dong, Y., Wang, Q., Yao, H., Xiao, Y., Wei, J., Xie, P., Hu, J., Chen, W., Tang, Y., Zhou, H., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28359 · Cited by 6
Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRIPreprint
McKay, N. S., Gordon, B. A., Hornbeck, R. C., Jack, C. R., Koeppe, R. A., Flores, S. E., Keefe, S., Hobbs, D. A., Joseph‐Mathurin, N., Wang, Q., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.25.485799 · Cited by 9
Self-citationMao, X., Li, A., Wang, Y., Wang, Y., Ren, S., He, K., Guan, Y., Huang, Q., Guo, Q., Li, Z., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07080-x · Cited by 6
Barber, P., Schaeffer, M. J., & Chan, L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303011 · Cited by 6
Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease
Erhardt, E. B., Horner, A., Shaff, N. A., Wertz, C., Nitschke, S. R., Vakhtin, A. A., Mayer, A. R., Adair, J. C., Knoefel, J. E., Rosenberg, G. A., et al. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2023.100199 · Cited by 6
Differential Diagnosis of Cognitive Decline in Elderly Individuals With Multiple Sclerosis
Jakimovski, D., Szigeti, K., Jaworski, M. G., Ouf, A., Weinstock‐Guttman, B., Zivadinov, R., & Benedict, R. H. B. (2020) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000252 · Cited by 6
Zheng, D., Xue, C., Feng, Y., Ruan, Y., Qi, W., Yuan, Q., Li, Z., & Xiao, C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1506478 · Cited by 5
Callow, D. D., Rani, N., Alm, K. H., Pettigrew, C. A., Soldan, A., Sheikhbahaei, S., Miller, M. I., Albert, M., & Bakker, A. (2025) · Hippocampus · doi:10.1002/hipo.70038 · Cited by 5
Singh, R. K., Bekena, S., Zhu, Y., Trani, J., Briggs, A., Bubu, O. M., Lucey, B. P., Ances, B. M., Babulal, G. M., & for the Aging Adult Brain Connectome (AABC) study team (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70940 · Cited by 5
Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies
Chin, K. S., Gajamange, S. I., Desmond, P. M., Villemagne, V. L., Rowe, C. C., Churilov, L. P., Yassi, N., & Watson, R. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221081773 · Cited by 5
Recent Advancements in the Early Diagnosis and Treatment of Alzheimer's Disease
Wu, Y., Fu, L., Li, Q., Gao, X., Zhang, Y., Jin, C., Ding, F., Hong, S. C., Cai, H., & Li, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300181 · Cited by 4
Teipel, S. J., Dyrba, M., Levin, F., Altenstein, S., Berger, M., Beyle, A., Brosseron, F., Büerger, K., Burow, L., Dobisch, L., et al. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230027 · Cited by 5
Simon, S. S., Varangis, E. M. L., Lee, S., Gu, Y., Gazes, Y., Razlighi, Q. R., Habeck, C. G., & Stern, Y. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.10.001 · Cited by 5
Emmerson, J. T., Carmo, S. D., Lavagna, A., Huang, C., Wong, T. P., Martínez-Trujillo, J., & Cuello, A. C. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01901-0 · Cited by 5
Lo, Y. L., & Cheng, S. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-7327-7_7 · Cited by 5
Metadata
- Authors
- Aschenbrenner, A. J., Gordon, B. A., Benzinger, T. L. S., Morris, J. C., & Hassenstab, J. J.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Venue
- Neurology
- Published
- 2018-08-28
- Volume
- 91
- Issue
- 9
- Pages
- e859-e866
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC6133625
- OpenAlex
- W2887375324
- Cited by
- 290
- References
- 19
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 27 · 2023: 31 · 2022: 48 · 2021: 46 · 2020: 33 · 2019: 29 · 2018: 6
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P50AG005681, P01AG003991, U01AG032438, P01AG026276, K01AG053474)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, tau PET, amyloid PET, hippocampal volume, cognitive decline, neuroimaging biomarkers, episodic memory, executive function, processing speed, semantic fluency
- MeSH terms
- Aged, Alzheimer Disease, Amyloid, Cognition Disorders, Female, Hippocampus, Humans, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Cohort Studies, tau Proteins, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
